Company profile

Redoxis company profile

Redoxis is a preclinical CRO with focus on inflammation and autoimmune conditions. They provide in vivo of RA, MS, GBS and SLE. In addition, they have a fully equipped lab with capacity to perform in vitro and ex vivo follow up assays and a wide range of immunology assays to provide you everything form MoA studies to PK and in vivo efficacy studies. Please visit www.redoxis.com for further information or contact us directly for quotes and discussion on model selection (free of charge).

Business identity

Contact email
[email protected]
Phone number
+46707259565
Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Revenue range
$0+
Founded
2007-01-01

Headquarters

Headquarters
Lund, Skane Lan, Sweden
Postal code
223 81
Country code
SE
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Grant / 2022-01-11
Investors
1
Lead investors
1

Categories and groups

Founders and investors

Lead investors

Eurostars

Investors

Eurostars

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.